BLRX Stock Analysis: Buy, Sell, or Hold?
BLRX - BioLineRX Ltd
$3.01
-0.10 (-3.21%)
▼
5d:
-2.27%
30d:
+8.67%
90d:
-12.75%
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Nov 24, 2025
0d
Get Alerted When BLRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BLRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: BLRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: BLRX is currently trading at $3.01, which is considered slightly high relative to its 30-day fair value range of $2.84 to $3.04.
Technical Outlook: Technically, BLRX is in a strong downtrend. Immediate support is located at $2.70, while resistance sits at $3.18. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: BLRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $26.00 (+736.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BLRX is in a strong downtrend. Immediate support is located at $2.70, while resistance sits at $3.18. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: BLRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $26.00 (+736.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$2.84 -
$3.04
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
73.7%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.2%)
- BULLISH: Trading 736.0% below Wall St target ($26.00)
Fair Price Analysis
30-Day Fair Range
$2.84 -
$3.04
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.70
Resistance Level
$3.18
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-4.64
Wall Street Target
$26.00
(+736.0%)
Revenue Growth (YoY)
-94.4%
Profit Margin
-45.3%
Last updated: February 02, 2026 9:48 AM ET
Data refreshes hourly during market hours. Next update: 10:48 AM
Data refreshes hourly during market hours. Next update: 10:48 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$477 | 45 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$215 | 60 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 56 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$277 | 59 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$19 | 55 HOLD |
